Detalles de la búsqueda
1.
Dobutamine stress echocardiography during transcatheter edge-to-edge mitral valve repair predicts residual mitral regurgitation.
Catheter Cardiovasc Interv
; 101(6): 1128-1133, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36994878
2.
Tricuspid regurgitation after transcatheter mitral valve repair: Clinical course and impact on outcome.
Catheter Cardiovasc Interv
; 98(3): E427-E435, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33458911
3.
Final five-year results of the REMEDEE Registry: Real-world experience with the dual-therapy COMBO stent.
Catheter Cardiovasc Interv
; 98(3): 503-510, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33029937
4.
Sex differences in 1-year clinical outcomes after percutaneous coronary intervention with COMBO stents: From the COMBO collaboration.
Catheter Cardiovasc Interv
; 97(5): 797-804, 2021 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32198837
5.
One-Year COMBO Stent Outcomes in Acute Coronary Syndrome: from the COMBO Collaboration.
Cardiovasc Drugs Ther
; 35(2): 309-320, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33515411
6.
Bioresorbable Scaffolds versus Metallic Stents in Routine PCI.
N Engl J Med
; 376(24): 2319-2328, 2017 06 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28402237
7.
One-year clinical outcomes in patients with chronic kidney disease treated with COMBO stents: From the COMBO collaboration.
Catheter Cardiovasc Interv
; 2020 Sep 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-32964556
8.
Clinical outcomes at 2 years of the Absorb bioresorbable vascular scaffold versus the Xience drug-eluting metallic stent in patients presenting with acute coronary syndrome versus stable coronary disease-AIDA trial substudy.
Catheter Cardiovasc Interv
; 95(1): 89-96, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30968559
9.
A sirolimus-eluting bioabsorbable polymer-coated stent (MiStent) versus an everolimus-eluting durable polymer stent (Xience) after percutaneous coronary intervention (DESSOLVE III): a randomised, single-blind, multicentre, non-inferiority, phase 3 trial.
Lancet
; 391(10119): 431-440, 2018 02 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29203070
10.
Myocardial fibrosis predicts adverse outcome after MitraClip implantation.
Catheter Cardiovasc Interv
; 93(6): 1146-1149, 2019 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30508272
11.
Three-year clinical outcomes after dual-therapy COMBO stent placement: Insights from the REMEDEE registry.
Catheter Cardiovasc Interv
; 94(3): 342-347, 2019 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30565371
12.
CT determined psoas muscle area predicts mortality in women undergoing transcatheter aortic valve implantation.
Catheter Cardiovasc Interv
; 93(4): E248-E254, 2019 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30208263
13.
Five-year follow-up of the endothelial progenitor cell capturing stent versus the paxlitaxel-eluting stent in de novo coronary lesions with a high risk of coronary restenosis.
Catheter Cardiovasc Interv
; 91(7): 1212-1218, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-28868810
14.
What is the best ST-segment recovery parameter to predict clinical outcome and myocardial infarct size? Amplitude, speed, and completeness of ST-segment recovery after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
J Electrocardiol
; 50(6): 952-959, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-29153151
15.
Older coronary thrombus is an independent predictor of 1-year mortality in acute myocardial infarction.
Eur J Clin Invest
; 46(6): 501-10, 2016 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-26988709
16.
Influence of chronic kidney disease on anticoagulation levels and bleeding after primary percutaneous coronary intervention in patients treated with unfractionated heparin.
J Thromb Thrombolysis
; 41(3): 441-51, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26238770
17.
Ventricular arrhythmia burst is an independent indicator of larger infarct size even in optimal reperfusion in STEMI.
J Electrocardiol
; 49(3): 345-52, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27034119
18.
Long-term ischaemic and bleeding outcomes after primary percutaneous coronary intervention for ST-elevation myocardial infarction in the elderly.
Neth Heart J
; 23(10): 477-482, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26259967
19.
APPOSITION V: STENTYS coronary stent system clinical trial in subjects with ST-segment elevation myocardial infarction--rationale and design.
Am Heart J
; 168(5): 652-60, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25440792
20.
Amsterdam Investigator-initiateD Absorb strategy all-comers trial (AIDA trial): a clinical evaluation comparing the efficacy and performance of ABSORB everolimus-eluting bioresorbable vascular scaffold strategy vs the XIENCE family (XIENCE PRIME or XIENCE Xpedition) everolimus-eluting coronary stent strategy in the treatment of coronary lesions in consecutive all-comers: rationale and study design.
Am Heart J
; 167(2): 133-40, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24439973